Erectile dysfunction (ED) impacts an estimated 18 million men in the U.S. alone, yet it is rarely discussed openly. John Smith, DO, a urologist at University of Utah Health, addresses the barriers to ...

Antidepressant-induced sexual dysfunction encompasses a spectrum of disturbances—loss of libido, delayed orgasm or anorgasmia, erectile dysfunction and reduced genital sensitivity—that affect up to ...

LTR Pharma (ASX:LTP) said Strive Pharmacy becomes the exclusive US pharmacy ‘fulfilment partner’ for Roxus, providing the ...

Achieving and maintaining an erection requires the interaction between the neurological, arterial, hormonal and psychological functions of the body. [iStockphoto] Most complications related to ...

For the first time, a team of researchers has found a specific place in the human genome that raises a person's risk of erectile dysfunction. The discovery is a significant advancement in the ...

Add Yahoo as a preferred source to see more of our stories on Google. Erectile dysfunction can cause a “self-perpetuating cycle of anxiety and performance pressure,” says one expert. (Photo ...

By our early 40s, one in five UK adults have entirely stopped having sex – but one Somerset duo is on a mission to change ...

Brazilian scientists have developed an erectile dysfunction treatment derived from the venom of P. nigriventer, which is already being tested in human trials. Reading time 2 minutes Men looking for a ...

Shed today announced exclusive U.S. direct-to-consumer telehealth rights to ROXUS®, a rapid-acting intranasal treatment for erectile dysfunction developed by LTR Pharma. ROXUS® will be available ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...